Patented Technology of Caesar Rivise, PC Client LifeAire Systems Removes COVID-19 from Air
Posted on Mar 26, 2020 in Articles
LifeAire Systems, a leader in air purification for healthcare, was featured in the March 24, 2020 issue of Lehigh Valley Business in an article titled “Local company makes air purification systems that kill COVID-19.”https://www.lvb.com/local-company-makes-air-purification-systems-kills-covid-19/? LifeAire’s patented design is mathematically and genomically modeled to kill or inactivate the most infectious biological pathogens, including–but not limited to–anthrax spores, COVID-19 (Coronavirus), tuberculosis, and influenza on a single pass through the system.
The innovative multi-stage air purification system of LifeAire’s patented Aire~IVF® System was invented by Kathryn C. Worrilow, PhD., Founder and CEO of LifeAire Systems. Dr. Worrilow has been awarded five U.S. patents covering the system, which also is protected by patents in Canada, Mexico, China, Germany, Spain, Italy, the UK, the Netherlands, and Israel. LifeAire’s air purification systems have for years improved clinical outcomes at in vitro fertilization facilities across the United States, Canada, and China.
LifeAire Systems is an innovative healthcare technology company in Allentown, PA that discovers, develops, manufactures and commercializes revolutionary air filtration systems for the healthcare and life sciences industry. Attorney James Kozuch, resident attorney of Caesar Rivise’s Allentown office, and several other attorneys in the firm’s Philadelphia office have been intellectual property counsel to Dr. Worrilow and her company since 2009, and procured the U.S. and international patents on Dr. Worrilow’s innovative air purification system, including U.S. Patent Nos. 8252099, 8252100, 9522210, 9675725 and 9980748.
In addition to being able to reduce the spread of communicable diseases such as influenza, COVID-19 (Coronavirus), tuberculosis, and measles, Dr. Worrilow’s patented system may also help address the major problem of hospital acquired infections, thereby helping to protect a wide range of patients from infants in the neonatal intensive care unit, to patients in the operating room, and to the elderly in long-term care facilities.